What i wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy

Familial Cancer

Volumn 10, Issue 1, 2011, Pages 79-85

  Campfield Bonadies, Danielle ^a   Moyer, Anne ^b   Matloff, Ellen T ^a  

^a YALE CANCER CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

BRCA1 and BRCA2; Prophylactic bilateral salpingo oophorectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; FEMALE; GENETIC COUNSELING; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; SALPINGOOOPHORECTOMY; SEXUAL BEHAVIOR; SEXUALITY; WOMEN'S HEALTH;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOT FLASHES; HUMANS; MIDDLE AGED; MUTATION; OVARIECTOMY; QUESTIONNAIRES; RETROSPECTIVE STUDIES; WOMEN'S HEALTH;

EID: 79951854492     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9384-z     Document Type: Article

References (27)

1. ND Kauff, et al. 2002 Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 21 1609 1615 10.1056/NEJMoa020119 12023992 (Pubitemid 34755668)
2. D Stirling, et al. 2005 Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international federation of gynecology and obstetrics system J Clin Oncol 23 24 5588 5596 10.1200/JCO.2005.05.097 16110018
3. TR Rebbeck 2000 Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers J Clin Oncol 18 21 100S 103S 1:STN:280:DC%2BD3M%2FjsVKqtg%3D%3D 11060335
4. J Struewing P Hartge S Wacholder 1997 The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 1401 1408 1:STN:280:DyaK2s3nsVShug%3D%3D 10.1056/NEJM199705153362001 9145676 (Pubitemid 27208598)
5. D Ford D Easton D Bishop 1994 Risks of cancer in BRCA1 mutation carriers Lancet 343 692 695 1:STN:280:DyaK2c7otVKitQ%3D%3D 10.1016/S0140-6736(94)91578-4 7907678 (Pubitemid 24087847)
6. A Antoniou P Pharoah S Narod 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analyses of 22 studies Am J Hum Genet 72 1117 1:CAS:528:DC%2BD3sXjslagtbg%3D 10.1086/375033 12677558 (Pubitemid 36530000)
7. NIH Consensus Conference 1995 Ovarian cancer: screening, treatment, and follow-up. NIH consensus development panel on ovarian cancer JAMA 273 491 497 10.1001/jama.273.6.491
8. S Domchek T Friebel S Neuhausen, et al. 2006 Mortality reduction after risk-reducing bilateral salpingo-oophorectomy in a prospective cohort of BRCA1 and BRCA2 mutation carriers Lancet Oncol 7 3 223 229 1:CAS:528: DC%2BD28XitVeitLs%3D 10.1016/S1470-2045(06)70585-X 16510331 (Pubitemid 43286452)
9. TR Rebbeck, et al. 2002 Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 1616 1622 10.1056/NEJMoa012158 12023993 (Pubitemid 34755669)
10. A Finch M Beiner J Lubinski, et al. 2006 Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation J Am Med Assoc 296 2 185 192 1:CAS:528:DC%2BD28XmvFeiu7w%3D 10.1001/jama.296.2.185 (Pubitemid 44050372)
11. NCCN practice guidelines in oncology v.1.2009 (2010): Hereditary breast and ovarian cancer. Available via: http://www.nccn.org/professionals/physician- gls/f-guidelines.asp Cited July 26, 2010
12. American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins-Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists 2009 ACOG practice bulletin no. 103: hereditary breast and ovarian cancer syndrome Obstet Gynecol 113 4 957 966
13. AR Bradbury, et al. 2008 Uptake and timing of prophylactic salpingo-oophorectomy among BRCA mutation carriers Genet Med 10 3 161 166 10.1097/GIM.0b013e318163487d 18344704 (Pubitemid 351416811)
14. EJ Meijers-Heijboer, et al. 2000 Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation Lancet 355 2015 2020 1:CAS:528:DC%2BD3cXksl2lt7s%3D 10.1016/S0140-6736(00)02347-3 10885351 (Pubitemid 30339238)
15. GA Bachmann 1999 Vasomotor flushes in menopausal women Am J Obstet Gynecol 180 S312 S316 1:STN:280:DyaK1M7nslSjtQ%3D%3D 10.1016/S0002-9378(99) 70725-8 10076170
16. M Taylor 2001 Psychological consequences of surgical menopause J Reprod Med 46 317 324 1:STN:280:DC%2BD3MvjsFeksg%3D%3D 11304879 (Pubitemid 32295142)
17. JB Madalinska, et al. 2005 Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer J Clin Oncol 23 6890 6898 10.1200/JCO.2005.02.626 16129845
18. J Stephenson 2003 FDA orders estrogen safety warnings: agency offers guidance for HRT use JAMA 289 537 538 10.1001/jama.289.5.537 12578468 (Pubitemid 37428620)
19. JB Madalinska, et al. 2006 The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy J Clin Oncol 24 22 3576 3582 10.1200/JCO.2005.05.1896 16877724 (Pubitemid 46630529)
20. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds) (1975-2006) SEER cancer statistics review. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009
21. L Elit, et al. 2001 Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer Fam Cancer 1 149 156 1:STN:280:DC%2BD3svps1Snug%3D%3D 10.1023/A:1021119405814 14574171 (Pubitemid 35407936)
22. N Hallowell 2000 A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy Psychooncology 9 486 495 1:STN:280:DC%2BD3M7jtVKltQ%3D%3D 10.1002/1099-1611(200011/12)9:6<486::AID- PON478>3.3.CO;2-P 11180583 (Pubitemid 32010921)
23. EM Swisher, et al. 2001 Prophylacic oophorectomy and ovarian cancer surveillance: patient perceptions and satisfaction J Reprod Med 46 87 94 1:STN:280:DC%2BD3Mvnt1KjsA%3D%3D 11255821 (Pubitemid 32205249)
24. A Fry, et al. 2001 Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer? Prev Med 33 578 585 1:STN:280:DC%2BD3MnntFOltg%3D%3D 10.1006/pmed.2001.0924 11716653 (Pubitemid 34101881)
25. SM Miller, et al. 1999 Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications Gynecol Oncol 75 406 412 1:STN:280:DC%2BD3c%2FmvFGgsQ%3D%3D 10.1006/gyno.1999.5611 10600298
26. C Marwick 1999 Survey says patients expect little physician help on sex JAMA 281 23 2173 2174 1:STN:280:DyaK1MzgtlSntw%3D%3D 10.1001/jama.281.23.2173 10376552 (Pubitemid 29275691)
27. ET Matloff RE Barnett SL Bober 2009 Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers Cancer J 15 1 15 18 10.1097/PPO.0b013e31819585f1 19197168